Yi Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi Cai has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
- Jolie L. Chang
Department of Otolaryngology, Head and Neck Surgery University of California, San Francisco School of Medicine San Francisco California USA
4 shared publications Jolie L. Chang
3 shared publications- Andrew N. Goldberg
University of California, San Francisco
2 shared publications Arushi Gulati
University of California School of Medicine, San Francisco
2 shared publications- Arushi Gulati
Department of Otolaryngology–Head and Neck Surgery University of California San Francisco California USA
2 shared publications - Derek J. Lam
Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon
2 shared publications
Latest Publications
- 4 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 1031-1039
Obstructive Sleep Apnea in Head and Neck Cancer Patients After Primary Treatment: A Review Focused on Oropharyngeal Cancer
Objective: Obstructive sleep apnea (OSA) is a disorder with significant health implications. Variations in upper airway anatomy and pharyngeal tone are factors that predispose patients to OSA. Oropharyngeal cancer (OPC) may increase the risk of OSA due to treatment‐induced changes in the upper airway. This scoping review aims to assess the prevalence of OSA in OPC patients post‐treatment. Data Sources: A search was conducted across multiple databases, including PubMed, Embase, and Cochrane Library, to identify studies reporting the prevalence of OSA in OPC patients post‐treatment (including surgery, radiation, and/or chemoradiation). Review Methods: Studies were screened for eligibility by two reviewers. Inclusion criteria required studies to use standardized diagnostic criteria for OSA and provide prevalence data specifically for post‐treatment OPC patients. Results: The search identified 788 studies: 30 underwent full‐text review, and 13 studies with 373 head and neck cancer (HNC) patients met inclusion criteria. The majority of studies did not disaggregate data for OPC from other subsites; one study provided sufficient data on OSA prevalence in OPC patients post‐treatment. Five studies reported AHI changes pre‐ and post‐treatment with a mean change of 5.4 events/h with only 2 studies reporting significant changes in OSA rates. Sleep‐related symptoms were captured in 11 studies with 2 comparing pre‐ and post‐treatment. Conclusion: Despite the growing recognition of OSA as a potential comorbidity in cancer survivors, the literature does not adequately address the prevalence of OSA in OPC patients post‐treatment. This highlights the need for future studies targeting OSA prevalence in this population using standardized diagnostic methods and reporting criteria.
- 4 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 1031-1039
Obstructive Sleep Apnea in Head and Neck Cancer Patients After Primary Treatment: A Review Focused on Oropharyngeal Cancer
Objective: Obstructive sleep apnea (OSA) is a disorder with significant health implications. Variations in upper airway anatomy and pharyngeal tone are factors that predispose patients to OSA. Oropharyngeal cancer (OPC) may increase the risk of OSA due to treatment‐induced changes in the upper airway. This scoping review aims to assess the prevalence of OSA in OPC patients post‐treatment. Data Sources: A search was conducted across multiple databases, including PubMed, Embase, and Cochrane Library, to identify studies reporting the prevalence of OSA in OPC patients post‐treatment (including surgery, radiation, and/or chemoradiation). Review Methods: Studies were screened for eligibility by two reviewers. Inclusion criteria required studies to use standardized diagnostic criteria for OSA and provide prevalence data specifically for post‐treatment OPC patients. Results: The search identified 788 studies: 30 underwent full‐text review, and 13 studies with 373 head and neck cancer (HNC) patients met inclusion criteria. The majority of studies did not disaggregate data for OPC from other subsites; one study provided sufficient data on OSA prevalence in OPC patients post‐treatment. Five studies reported AHI changes pre‐ and post‐treatment with a mean change of 5.4 events/h with only 2 studies reporting significant changes in OSA rates. Sleep‐related symptoms were captured in 11 studies with 2 comparing pre‐ and post‐treatment. Conclusion: Despite the growing recognition of OSA as a potential comorbidity in cancer survivors, the literature does not adequately address the prevalence of OSA in OPC patients post‐treatment. This highlights the need for future studies targeting OSA prevalence in this population using standardized diagnostic methods and reporting criteria.
- 22 March 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3406-3411
Impact of Hypoglossal Nerve Stimulation on Consumer Sleep Technology Metrics and Patient Symptoms
Objectives: Obstructive sleep apnea (OSA) is usually assessed at discrete and infrequent timepoints. Wearable consumer sleep technologies (CST) may allow for more granular and longitudinal assessments of OSA therapy responses and OSA‐related symptoms.Methods: In this case series, we enrolled hypoglossal nerve stimulator (HGNS) patients who had an effective treatment response for an 8‐week study using a wearable CST. Participants started with “HGNS‐on,” were randomized to turn off HGNS therapy during either week 4 or 5 (“HGNS‐off”), followed by a return to therapy, “HGNS‐resume.” Participants completed validated symptom questionnaires assessing sleepiness, insomnia symptoms, functional status, and overall sleep health (Satisfaction, Alertness, Timing, Efficiency, and Duration, SATED) each week. CST metrics and survey scores were compared between HGNS treatment phases. Associations between CST metrics and survey scores were assessed.Results: Seven participants with a total of 304 nights of CST data showed no statistically significant changes in total sleep time (TST), wake time after sleep onset, or sleep efficiency (SE) across the study periods. During HGNS‐off, survey scores indicated significantly worsened OSA‐related symptom scores. Two participants had significantly higher heart rate variability (HRV) during HGNS‐off (by 3.3 and 6.3 ms) when compared to HGNS active therapy periods. Amongst CST metrics, SATED scores correlated with TST (r = 0.434, p < 0.0001), HRV (r = −0.486, p < 0.0001), and SE (r = 0.320, = 0.0014). In addition, FOSQ‐10 scores correlated with average HR during sleep (r = −0.489, p < 0.001).Conclusion: A 1‐week HGNS therapy withdrawal period impacted OSA‐related sleep symptoms. Sleep‐related metrics measured by a wearable CST correlated with symptom scores indicating potential value in the use of CSTs for longitudinal sleep‐tracking in OSA patients.Level of Evidence: 4 Laryngoscope, 134:3406–3411, 2024
- 22 March 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3406-3411
Impact of Hypoglossal Nerve Stimulation on Consumer Sleep Technology Metrics and Patient Symptoms
Objectives: Obstructive sleep apnea (OSA) is usually assessed at discrete and infrequent timepoints. Wearable consumer sleep technologies (CST) may allow for more granular and longitudinal assessments of OSA therapy responses and OSA‐related symptoms.Methods: In this case series, we enrolled hypoglossal nerve stimulator (HGNS) patients who had an effective treatment response for an 8‐week study using a wearable CST. Participants started with “HGNS‐on,” were randomized to turn off HGNS therapy during either week 4 or 5 (“HGNS‐off”), followed by a return to therapy, “HGNS‐resume.” Participants completed validated symptom questionnaires assessing sleepiness, insomnia symptoms, functional status, and overall sleep health (Satisfaction, Alertness, Timing, Efficiency, and Duration, SATED) each week. CST metrics and survey scores were compared between HGNS treatment phases. Associations between CST metrics and survey scores were assessed.Results: Seven participants with a total of 304 nights of CST data showed no statistically significant changes in total sleep time (TST), wake time after sleep onset, or sleep efficiency (SE) across the study periods. During HGNS‐off, survey scores indicated significantly worsened OSA‐related symptom scores. Two participants had significantly higher heart rate variability (HRV) during HGNS‐off (by 3.3 and 6.3 ms) when compared to HGNS active therapy periods. Amongst CST metrics, SATED scores correlated with TST (r = 0.434, p < 0.0001), HRV (r = −0.486, p < 0.0001), and SE (r = 0.320, = 0.0014). In addition, FOSQ‐10 scores correlated with average HR during sleep (r = −0.489, p < 0.001).Conclusion: A 1‐week HGNS therapy withdrawal period impacted OSA‐related sleep symptoms. Sleep‐related metrics measured by a wearable CST correlated with symptom scores indicating potential value in the use of CSTs for longitudinal sleep‐tracking in OSA patients.Level of Evidence: 4 Laryngoscope, 134:3406–3411, 2024
- Top Cited Papers
- 30 March 2023
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 13 (7) , 1061-1482
International Consensus Statement on Obstructive Sleep Apnea
Background: Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA).Methods: Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence‐based review (EBR), or evidence‐based review with recommendations (EBR‐R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus.Results: The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic testing types, multiple treatment modalities, and effects of OSA treatment on multiple OSA‐associated comorbidities. Specific focus on outcomes with positive airway pressure (PAP) and surgical treatments were evaluated.Conclusion: This review of the literature consolidates the available knowledge and identifies the limitations of the current evidence on OSA. This effort aims to create a resource for OSA evidence‐based practice and identify future research needs. Knowledge gaps and research opportunities include improving the metrics of OSA disease, determining the optimal OSA screening paradigms, developing strategies for PAP adherence and longitudinal care, enhancing selection of PAP alternatives and surgery, understanding health risk outcomes, and translating evidence into individualized approaches to therapy.
- 30 March 2023
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 13 (7) , 1061-1482
Top Cited PapersInternational Consensus Statement on Obstructive Sleep Apnea
Background: Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA).Methods: Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence‐based review (EBR), or evidence‐based review with recommendations (EBR‐R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus.Results: The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic testing types, multiple treatment modalities, and effects of OSA treatment on multiple OSA‐associated comorbidities. Specific focus on outcomes with positive airway pressure (PAP) and surgical treatments were evaluated.Conclusion: This review of the literature consolidates the available knowledge and identifies the limitations of the current evidence on OSA. This effort aims to create a resource for OSA evidence‐based practice and identify future research needs. Knowledge gaps and research opportunities include improving the metrics of OSA disease, determining the optimal OSA screening paradigms, developing strategies for PAP adherence and longitudinal care, enhancing selection of PAP alternatives and surgery, understanding health risk outcomes, and translating evidence into individualized approaches to therapy.
- 21 June 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (10) , 2384-2390
Characterizing Decisional Conflict in Patients Presenting to Sleep Surgery Clinic and an Exploration of Resource Limitations
Objectives: Numerous therapies exist for adult obstructive sleep apnea (OSA), creating potential for patient decisional conflict (DC) that impacts treatment adherence and post‐treatment regret. We evaluated the prevalence of elevated DC in OSA patients presenting for positive airway pressure (PAP) alternative therapies and identified gaps in available resources about OSA therapies.Study Design: Cross‐sectional study.Methods: A cross‐sectional study was performed based on questionnaires completed by adult OSA patients presenting to an academic sleep surgery clinic from March to October 2020. Surveys examined sleep symptoms, sleep apnea treatment history, goals of therapy, and the SURE checklist, a validated 4‐item DC screening scale. Additional qualitative data about OSA decision tool needs were queried with structured interviews in a smaller subset of patients.Results: Among 100 respondents, 60 were open to multiple treatment options, whereas 22 were not interested in surgical treatment. Eighty‐one respondents (81%) had elevated DC (SURE score < 4). High DC was not associated with CPAP history, OSA severity, or daytime sleepiness (Epworth Sleepiness Scale score ≥ 10). Elevated DC was related to uncertainty regarding optimal treatment choice in 54% of respondents (n = 54), and lack of knowledge regarding risks and benefits of each treatment option in 71% (n = 71). Common themes identified in 9 interviewed patients suggested helpful resources should ideally compare treatment modalities and educate on surgery details, efficacy, and recovery.Conclusions: The majority of OSA patients presenting to sleep surgery clinics have elevated decisional conflict influenced by limited knowledge about options and the risks and benefits of each therapy. There is a need for decision tools that can reduce decisional conflict and promote equitable knowledge about PAP alternative OSA treatments.Level of Evidence: 4 Laryngoscope, 131:2384–2390, 2021
- 21 June 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (10) , 2384-2390
Characterizing Decisional Conflict in Patients Presenting to Sleep Surgery Clinic and an Exploration of Resource Limitations
Objectives: Numerous therapies exist for adult obstructive sleep apnea (OSA), creating potential for patient decisional conflict (DC) that impacts treatment adherence and post‐treatment regret. We evaluated the prevalence of elevated DC in OSA patients presenting for positive airway pressure (PAP) alternative therapies and identified gaps in available resources about OSA therapies.Study Design: Cross‐sectional study.Methods: A cross‐sectional study was performed based on questionnaires completed by adult OSA patients presenting to an academic sleep surgery clinic from March to October 2020. Surveys examined sleep symptoms, sleep apnea treatment history, goals of therapy, and the SURE checklist, a validated 4‐item DC screening scale. Additional qualitative data about OSA decision tool needs were queried with structured interviews in a smaller subset of patients.Results: Among 100 respondents, 60 were open to multiple treatment options, whereas 22 were not interested in surgical treatment. Eighty‐one respondents (81%) had elevated DC (SURE score < 4). High DC was not associated with CPAP history, OSA severity, or daytime sleepiness (Epworth Sleepiness Scale score ≥ 10). Elevated DC was related to uncertainty regarding optimal treatment choice in 54% of respondents (n = 54), and lack of knowledge regarding risks and benefits of each treatment option in 71% (n = 71). Common themes identified in 9 interviewed patients suggested helpful resources should ideally compare treatment modalities and educate on surgery details, efficacy, and recovery.Conclusions: The majority of OSA patients presenting to sleep surgery clinics have elevated decisional conflict influenced by limited knowledge about options and the risks and benefits of each therapy. There is a need for decision tools that can reduce decisional conflict and promote equitable knowledge about PAP alternative OSA treatments.Level of Evidence: 4 Laryngoscope, 131:2384–2390, 2021
- Open Access
- 1 April 2021
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 147 (4) , 336-342
Patient Use of Low-cost Digital Videoscopes and Smartphones for Remote Ear and Oropharyngeal Examinations
Although telehealth has been historically underused due to technological barriers, high implementation costs, and limited clinician reimbursement,1,2 it has become commonplace during the novel coronavirus disease 2019 (COVID-19) pandemic as a way of reducing viral spread while delivering clinical care. New federal legislation has accelerated telehealth adoption with improved reimbursement of telemedicine visits and temporary changes to videoconferencing regulations.3,4 Given the rate of health system investment in telemedicine infrastructure during the COVID-19 pandemic, continued growth and widespread adoption are expected.
- 1 April 2021
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 147 (4) , 336-342
Open AccessPatient Use of Low-cost Digital Videoscopes and Smartphones for Remote Ear and Oropharyngeal Examinations
Although telehealth has been historically underused due to technological barriers, high implementation costs, and limited clinician reimbursement,1,2 it has become commonplace during the novel coronavirus disease 2019 (COVID-19) pandemic as a way of reducing viral spread while delivering clinical care. New federal legislation has accelerated telehealth adoption with improved reimbursement of telemedicine visits and temporary changes to videoconferencing regulations.3,4 Given the rate of health system investment in telemedicine infrastructure during the COVID-19 pandemic, continued growth and widespread adoption are expected.
- 11 March 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (8)
The microbiome in obstructive sleep apnea
Recent evidence has highlighted important associations between obstructive sleep apnea and the microbiome. Although the intricacies of the pathophysiologic mechanisms are not well understood, available evidence suggests a bidirectional relationship between obstructive sleep apnea and microbiota composition. Sleep fragmentation, intermittent hypoxia, and intermittent hypercapnia all play significant roles in altering the microbiome, and initial evidence has shown that alterations of the microbiota affect sleep patterns. Animal model evidence strongly supports the idea that the microbiome mediates disease states associated with obstructive sleep apnea including hypertension, atherosclerosis, and obesity. While evidence is limited, several studies suggest there may be a role for treatment of obstructive sleep apnea and obstructive sleep apnea-related comorbidities through alteration of the microbiome with probiotics, prebiotics, and microbiota transplantation.
- 11 March 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (8)
The microbiome in obstructive sleep apnea
Recent evidence has highlighted important associations between obstructive sleep apnea and the microbiome. Although the intricacies of the pathophysiologic mechanisms are not well understood, available evidence suggests a bidirectional relationship between obstructive sleep apnea and microbiota composition. Sleep fragmentation, intermittent hypoxia, and intermittent hypercapnia all play significant roles in altering the microbiome, and initial evidence has shown that alterations of the microbiota affect sleep patterns. Animal model evidence strongly supports the idea that the microbiome mediates disease states associated with obstructive sleep apnea including hypertension, atherosclerosis, and obesity. While evidence is limited, several studies suggest there may be a role for treatment of obstructive sleep apnea and obstructive sleep apnea-related comorbidities through alteration of the microbiome with probiotics, prebiotics, and microbiota transplantation.
- 1 January 2021
- Published by Inderscience Publishers in International Journal of Mobile Learning and Organisation
- Vol. 15 (4) , 358
Enhancing skill prediction through generalising Bayesian knowledge tracing
- 1 January 2021
- Published by Inderscience Publishers in International Journal of Mobile Learning and Organisation
- Vol. 15 (4) , 358
Enhancing skill prediction through generalising Bayesian knowledge tracing
- 14 September 2020
- Published by Wiley in Head & Neck
- Vol. 42 (12) , 3712-3719
Evolving Otolaryngology Resident Roles and Concerns at the Peak of the US COVID‐19 Pandemic
Background: The roles of US otolaryngology residents have changed in response to the coronavirus disease 2019 (COVID‐19) pandemic. As the pandemic peaked in the United States, we characterized resident activities and concerns.Methods: A cross‐sectional study of US otolaryngology residents between April 20, 2020 and May 2, 2020.Results: A total of 219 residents at 65/118 (55%) institutions responded. Thirty (14%) residents had been redeployed. Residents reported greatest concerns regarding education (P < .00001). Assuming adequate protective equipment, 55% desired active participation in high‐risk procedures on COVID‐19‐positive patients. Redeployed residents had greater concern for burnout and reduced in‐hospital well‐being (P < .05). Resident satisfaction correlated with comfort communicating concerns to their department (odds ratio [OR] = 4.9, 95% confidence interval [CI] 1.4‐17.3, P = .01) and inversely correlated with low perceived meaning in work (OR = 3.1, CI 1.1‐9.1, P = .03).Conclusion: Otolaryngology resident concerns have evolved as the pandemic progressed. Residency programs should prioritize resident education, well‐being in redeployed residents, and open communication as they transition toward recovery.
- 14 September 2020
- Published by Wiley in Head & Neck
- Vol. 42 (12) , 3712-3719
Evolving Otolaryngology Resident Roles and Concerns at the Peak of the US COVID‐19 Pandemic
Background: The roles of US otolaryngology residents have changed in response to the coronavirus disease 2019 (COVID‐19) pandemic. As the pandemic peaked in the United States, we characterized resident activities and concerns.Methods: A cross‐sectional study of US otolaryngology residents between April 20, 2020 and May 2, 2020.Results: A total of 219 residents at 65/118 (55%) institutions responded. Thirty (14%) residents had been redeployed. Residents reported greatest concerns regarding education (P < .00001). Assuming adequate protective equipment, 55% desired active participation in high‐risk procedures on COVID‐19‐positive patients. Redeployed residents had greater concern for burnout and reduced in‐hospital well‐being (P < .05). Resident satisfaction correlated with comfort communicating concerns to their department (odds ratio [OR] = 4.9, 95% confidence interval [CI] 1.4‐17.3, P = .01) and inversely correlated with low perceived meaning in work (OR = 3.1, CI 1.1‐9.1, P = .03).Conclusion: Otolaryngology resident concerns have evolved as the pandemic progressed. Residency programs should prioritize resident education, well‐being in redeployed residents, and open communication as they transition toward recovery.
- Open Access
- 12 May 2020
- Published by Wiley in The Laryngoscope
- Vol. 130 (11) , 2550-2557
Otolaryngology Resident Practices and Perceptions in the Initial Phase of the U.S. COVID‐19 Pandemic
Objective: The coronavirus 2019 (COVID‐19) pandemic has had widespread implications on clinical practice at U.S. hospitals. These changes are particularly relevant to otolaryngology–head and neck surgery (OHNS) residents because reports suggest an increased risk of contracting COVID‐19 for otolaryngologists. The objectives of this study were to evaluate OHNS residency program practice changes and characterize resident perceptions during the initial phase of the pandemic.Study Design: A cross‐sectional survey of U.S. OHNS residents at 81 programs was conducted between March 23, 2020, and March 29, 2020.Results: Eighty‐two residents from 51 institutions (63% of invited programs) responded. At the time of survey, 98% of programs had enacted policy changes to minimize COVID‐19 spread. These included filtered respirator use for aerosol‐generating procedures even in COVID‐19‐negative patients (85%), decreased resident staffing of surgeries (70%), and reduced frequency of tracheotomy care (61%). The majority of residents (66%) perceived that residents were at higher risk of contracting COVID‐19 compared to attendings. Residents were most concerned about protective equipment shortage (93%) and transmitting COVID‐19 to patients (90%). The majority of residents (73%) were satisfied with their department's COVID‐19 response. Resident satisfaction correlated with comfort level in discussing concerns with attendings (r = 0.72, P < .00001) and inversely correlated with perceptions of increased risk compared to attendings (r = −0.52, P < .00001).Conclusion: U.S. OHNS residency programs implemented policy changes quickly in response to the COVID‐19 pandemic. Sources of resident anxieties demonstrate the importance of open communication and an integrated team approach to facilitate optimal patient and provider care during this unprecedented crisis.Level of Evidence: 4. Laryngoscope, 130:2550–2557, 2020
- 12 May 2020
- Published by Wiley in The Laryngoscope
- Vol. 130 (11) , 2550-2557
Open AccessOtolaryngology Resident Practices and Perceptions in the Initial Phase of the U.S. COVID‐19 Pandemic
Objective: The coronavirus 2019 (COVID‐19) pandemic has had widespread implications on clinical practice at U.S. hospitals. These changes are particularly relevant to otolaryngology–head and neck surgery (OHNS) residents because reports suggest an increased risk of contracting COVID‐19 for otolaryngologists. The objectives of this study were to evaluate OHNS residency program practice changes and characterize resident perceptions during the initial phase of the pandemic.Study Design: A cross‐sectional survey of U.S. OHNS residents at 81 programs was conducted between March 23, 2020, and March 29, 2020.Results: Eighty‐two residents from 51 institutions (63% of invited programs) responded. At the time of survey, 98% of programs had enacted policy changes to minimize COVID‐19 spread. These included filtered respirator use for aerosol‐generating procedures even in COVID‐19‐negative patients (85%), decreased resident staffing of surgeries (70%), and reduced frequency of tracheotomy care (61%). The majority of residents (66%) perceived that residents were at higher risk of contracting COVID‐19 compared to attendings. Residents were most concerned about protective equipment shortage (93%) and transmitting COVID‐19 to patients (90%). The majority of residents (73%) were satisfied with their department's COVID‐19 response. Resident satisfaction correlated with comfort level in discussing concerns with attendings (r = 0.72, P < .00001) and inversely correlated with perceptions of increased risk compared to attendings (r = −0.52, P < .00001).Conclusion: U.S. OHNS residency programs implemented policy changes quickly in response to the COVID‐19 pandemic. Sources of resident anxieties demonstrate the importance of open communication and an integrated team approach to facilitate optimal patient and provider care during this unprecedented crisis.Level of Evidence: 4. Laryngoscope, 130:2550–2557, 2020